Electrically stimulated 5-hydroxytryptamine (5-HT) release was monitored in slices of rat dorsal raphe nucleus (DRN) by fast cylic voltammetry. Pseudo-single pulse stimulations (5 pulses at 100 Hz) were used to enable the effect of various receptor agonists to be seen without competition from endogenously 
Introduction The dorsal raphe nucleus (DRN) is one of the primary 5-hydroxytryptamine (5-HT) cell body areas and projects to most parts of the brain. Traditionally 5-HT neurotransmission in the DRN is thought to be under 5-HTIA receptor control: Stimulation of 5-HTlA autoreceptors slows raphe cell firing (Sprouse & Aghajanian, 1987) and decreases 5-HT release (Davidson & Stamford, 1994) .
Recently however, studies in the guinea-pig have shown that 5-HTlD autoreceptors can also influence 5-HT release in the DRN (Starkey & Skingle, 1994) . The rat homologue of the 5-HTIDp receptor is the 5-HTIB receptor (Hoyer et al., 1994) and we have now shown (Davidson & Stamford, 1994) that 5-HT release in the rat DRN may also be reduced by the 5-HTlB/D agonist, 2, 3, 5, 
pyridine).
The rat is not generally held to have functional 5-HTlD receptors, although mRNA for the rat homologue of the 5-HTID, receptor is found in the DRN (Hamblin et al., 1992) and it has been tentatively suggested that there may be functional 5-HTlD receptors in the rat DRN (Pineyro et al., 1994) . However these conclusions were largely based on the use of mianserin as a 5-HTID antagonist, a drug with only modest selectivity over 5-HTlB receptors (Hoyer et al., 1994) . In this study we have used selective agonists and antagonists for 5-HTlA, 5-HTIB and 5-HTlD receptors to determine which autoreceptors are involved in the control of electrically stimulated 5-HT release in the rat DRN.
Methods Brain slices Male Wistar rats (100-150 g) were killed by cervical dislocation. Brains were rapidly removed under ice-cold artificial cerebrospinal fluid (ACSF). Coronal slices (350 gLm) of DRN were taken at + 4.8 mm versus the interaural line (Paxinos & Watson, 1986) A sample and hold circuit was set to monitor current at the 5-HT oxidation potential, + 0.6 V versus Ag/AgCl and its output stored on computer.
Stimulation protocol The CFM was placed in the centre of the DRN and a bipolar stimulating electrode located 200gm ventrally. Pseudo-single pulse electrical stimulations consisting of five 0.1 ms duration pulses (100 Hz, 10 mA) were applied every 5 min. Stimulations were applied until 4 stable 5-HT release events were recorded, at which point the agonist was added for 40 min. Where an antagonist was also used, it was added to the superfusate at least 80 min before the agonist to allow any effect to reach a stable plateau.
Statistical analysis Each group of drugs was analysed by one-way ANOVA, followed by post-hoc application of the Tukey-Kramer test to locate significant differences. Probability levels of P<0.05 were deemed significant. (Hoyer et al., 1994) , had no significant effect. Although it is possible that, at this concentration (0.5 AM), sumatriptan has a small effect at the 5-HTIB receptor (pKB = 6.0: Hoyer et al., 1994) , the absence of effect of isamoltane makes this unlikely. The 5-HTIE subtype is also unlikely to explain the actions of sumatriptan and GR-127935 since their affinity at this site is at least 2 orders of magnitude lower than at the 5-HTID receptor (Starkey & Skingle, 1994) .
The observation of multiple functional 5-HTI subtypes in the DRN begs the question: where are these receptors located? The 5-HT1B receptor is often assumed to be a terminal autoreceptor and may therefore be located on terminals in the DRN from other 5-hydroxytryptaminergic nuclei (Kalen et al., 1985) or from axon collaterals within the DRN itself (Chazel & Ralston, 1987) . The presence of 5-HTID mRNA in the DRN (Hamblin et al., 1992) may suggest that DRN 5-HTID receptors are on dendrites or recurrent collaterals. Further work is in progress to clarify these mat-
